Mahoney will be based in the Heidelberg, Germany-based firm’s Boston office and will be responsible for managing US legal matters and the intellectual property portfolio of the Febit group, the company said.
Stuart Schwartz, Marilyn Slovak, Michael Liebman, Laura Reid, David Mahoney
Empire Genomics has named to its scientific advisory board Stuart Schwartz, Marilyn Slovak, Michael Liebman, and Laura Reid.
Schwartz is director of genetic diagnostic services and director of the Clinical Cytogenetics Laboratory at the University of Chicago.
Slovak is director of cytogenetics and professor of pathology at the City of Hope National Medical Center and is a fellow of the American Board of Medical Genetics College.
Liebman is executive director of the Windber Research Institute, managing director of Strategic Medicine, and chair of the Healthcare Task Force for the SMART program.
Reid is senior director of marketing and external scientific affairs at Expression Analysis and a member of the External RNA Controls Consortium and the ABRF Microarray Research Group.
Febit last week appointed David Mahoney as its director of global intellectual property and US legal affairs.